Main Newsletter
Mastery Series
Therapy Series
 

Items for the Week

Ordered by most recent

Lifestyle Counseling Cuts Heart Risks

U.S Preventive Services Task Force has shown that counseling makes a difference.... 


Breakfast Associated with Lower Risk of Type 2 Diabetes in Children

Children who reported eating a high fiber, cereal breakfast also had lower insulin resistance....


Abbott Announces Approval of Its New Unique Continuous Glucose Monitor

FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for people with diabetes, eliminates finger sticks....



Sugar Substance Reduces HDL

Scientists have discovered that 'good' cholesterol is turned 'bad' by a sugar-derived substance, methylglyoxal.... 


Lilly's Basal Insulin Peglispro Demonstrated HbA1c Superiority against Lantus

The rate of nocturnal hypoglycemia was also significantly lower in patients taking BIL.... 


Predicting Which Diabetics Will Develop Major Complications

A new model is presented for predicting which patients with type 1 diabetes will go on to develop major complications.... 


Screening Everyone 35 and Older Makes a Difference

The cost would be only marginally greater, new findings show.... 


Deficiency of a Gene May Increase Risk of Diabetes and Liver Cancer in Males

Why doesn't this gene affect females in the same way?...


U300 Insulin Glargine Produces Lower Rates of Night Time Hypoglycemia

A reduced risk of nocturnal hypoglycemia is among the advantages.... 


Diabetic Macular Edema (DME) Risk Higher for Non-Hispanic African American Patients

Risk is also higher for those who have had diabetes longer and have higher HbA1c levels.... 


Diet and Physical Activity Reduce Inflammatory Markers in Type 2

Both diet and diet plus physical activity interventions reduced inflammatory markers soon after type 2 diagnosis....


Sensor Implant Measures Blood pH in Type 1 Diabetes

The device, only tested in mice, also can release insulin to prevent acidosis.... 


CPAP Lowers BP and A1c in Patients with Obstructive Sleep Apnea and Type 2 Diabetes

Researchers also found that Quality of Life improved and costs were lowered.... 


Beta-Adrenergic Blockade Effects on Glucose Counterregulation in Advanced T2DM and Beta-Cell Failure

At normoglycemia, beta-adrenergic blockade may cause increased insulin sensitivity…. 


The Safety and Use of Oral Methazolamide in Type 2 Diabetes

Methazolamide, a carbonic anhydrase inhibitor, is a medication used to treat increased pressure inside the eye due to glaucoma.... 


Insulin Resistance's Effects on Tissue Iron Stores and Cognitive Performance

BIO (brain iron overload) could be a potentially useful MRI biomarker for insulin resistance and obesity-associated cognitive dysfunction.... 


Pistachios Associated with an Improved Metabolic Risk Profile in Prediabetes

In a study, patients who consumed pistachios showed improvement in fasting glucose, insulin, and HOMA of insulin resistance.... 


Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies

The glucose-reducing drug empagliflozin (Jardiance) now has approval from the FDA after the drug maker corrected manufacturing problems that caused the agency to say "no" in March....


Hypertension Control Can Prevent Renal Damage in Diabetics

Elevated blood pressure is associated with an increased risk of renal damage in patients with type 2 diabetes, especially if they have poor glycemic control.... 


New Way to Regenerate Beta Cells in Type 1 Diabetes

A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells....


CDC: 40% of American Adults Will Develop Diabetes

In Hispanic men and women, and non-Hispanic black women, the projected increased risk is even higher, over 50%....


Depressive Symptoms, Antidepressant Use, and Risk of Diabetes in African-American Women

Use of antidepressants was associated with a 26% higher risk of diabetes.... 


Printed Educational Messages to Promote Retinal Screening Not Effective

In a Canadian study, printed educational messages (PEMs) aimed at family practitioners were not effective in promoting retinal screening among diabetes patients....


Plasma Copeptin a Potential Marker for CVD in Asymptomatic T2DM Patients

Copeptin concentration also correlated to plasma creatinine and to PAD in T2DM patients.... 


A Novel Treatment for Type 2 Diabetes Patients

Tests in mice of recombinant human tissue kallikrein-1 show promise.... 


BG Levels during Acute Illness Can Help Predict Future Diabetes Risk

Blood glucose levels measured in hospitalized patients during acute illness predicted the risk of developing type 2 diabetes in the following three years.... 


New Ultra-Rapid-Acting Insulin Formulation

BIOD-531 is a new ultra-rapid-acting insulin formulation that has been shown to work better than current therapies at treating diabetes in a mid-stage trial.... 


Diabetic Neuropathy Improved with Vegan Diet

A randomized controlled trial indicates that a vegan diet may be beneficial in relieving diabetic nerve pain.... 


New Wearable Device Detects Diabetic Autonomic Neuropathy

Developed by Taiwanese researchers, the device can hang on a pair of glasses and is called a "pupillometer." ... 


Type 2 Diabetes Management More Difficult with Early Onset

Younger age groups may be at higher risk in developing complications, possibly due to later addition of statin medications….


Correlation between Insulin Sensitivity and Renal Problems

Renal abnormalities may be indicated by a specific key marker in type 2 diabetes.... 


Some Saturated Fats Can Protect against Diabetes

Not all saturated fatty acids are the same in relation to type 2 diabetes risk....


FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)

The US Food and Drug Administration has approved Invokamet, a fixed-dose therapy combining Invokana (canagliflozin) and metformin.... 


Should Non-diabetics Use Diabetes Drugs?

A study involving over 180,000 people showed that patients treated with metformin can live longer than non-diabetics.... 


The Importance of Control Solution

Control solution, used for ensuring the proper function of glucose meters, doesn't appear to be a priority among physicians, pharmacists, or patients.... 


Early Insulin Delays Diabetes But Are There Negative Consequences?

One researcher comments, "Please don't fall into this trap that you can prevent diabetes with insulin."…


Effects of Intensive Glycemic Control on Ischemic Heart Disease

How can three landmark trials of intensive vs standard glucose-lowering strategies -- ADVANCE, ACCORD, and VADT -- raise more questions than they answer?... 


Peripheral Neuropathy Associated with CV Disease and Stroke in Type 2 Diabetes Patients

Testing for peripheral neuropathy may provide a way to identify individuals at higher risk of cardiovascular events.... 


Dulaglutide vs. Exenatide as Add-On Therapy to Pioglitazone and Metformin in T2DM

Study seems to indicate superiority of dulaglutide, a long-acting GLP-1 receptor agonist that is administered once-weekly.... 


During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose

The effects of caffeine versus maltodextrin during exercise were observed in patients with type 2 diabetes.... 



Navigate through our listing of Items for the Week articles here.
First Previous Next Last

8899 Total articles for Items for the Week


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here


Cast Your Vote
Now that once-weekly dulaglutide has been approved, will you be prescribing it?
CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: Vascular Therapy
Credits: .75


Advertisement


Search Articles On Diabetes In Control